A TOTALITY-OF-THE-EVIDENCE APPROACH TO THE DEVELOPMENT OF GP2015, A PROPOSED ETANERCEPT BIOSIMILAR

被引：0
|
作者：
McCamish, M. [1 ]
DaSilva, A. [1 ]
Mayer, R. Ernst [2 ]
Fritsch, C. [3 ]
Schiestl, M. [2 ]
机构：
[1] Hexal AG, Holzkirchen, Germany
[2] Sandoz Biopharmaceut, Kundl, Austria
[3] Novartis Pharma AG, Basel, Switzerland
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.2959
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0321
引用
收藏
页码：1010 / 1010
页数：1
相关论文
共 50 条
  • [1] The totality-of-the-evidence approach to the development and assessment of GP2015, a proposed etanercept biosimilar
    Strand, Vibeke
    Girolomoni, Giampiero
    Schiestl, Martin
    Mayer, Robert Ernst
    Friccius-Quecke, Hilke
    McCamish, Mark
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (06) : 993 - 1003
  • [2] GP2015: An Etanercept Biosimilar
    Emma D. Deeks
    [J]. BioDrugs, 2017, 31 : 555 - 558
  • [3] GP2015: An Etanercept Biosimilar
    Deeks, Emma D.
    [J]. BIODRUGS, 2017, 31 (06) : 555 - 558
  • [4] Correction to: GP2015: An Etanercept Biosimilar
    Emma D. Deeks
    [J]. BioDrugs, 2018, 32 (5) : 525 - 525
  • [5] Characterization and non-clinical assessment of the proposed etanercept biosimilar GP2015 with originator etanercept (Enbrel®)
    Hofmann, Hans-Peter
    Kronthaler, Ulrich
    Fritsch, Cornelius
    Grau, Roger
    Mueller, Stefan O.
    Mayer, Robert
    Seidl, Andreas
    Da Silva, Antonio
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (10) : 1185 - 1195
  • [6] "Totality-of-the-evidence" of proposed ustekinumab biosimilar SB17"
    Armuzzi, A.
    Girolomoni, G.
    Feldman, S.
    Goncalves, J.
    Park, Y.
    Ye, B. D.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1832 - I1834
  • [7] GP2015: An Etanercept Biosimilar (vol 31, pg 555, 2018)
    Deeks, Emma D.
    [J]. BIODRUGS, 2018, 32 (05) : 525 - 525
  • [8] PHARMACOKINETICS AND SAFETY OF GP2015, A PROPOSED ETANERCEPT BIOSIMILAR, ADMINISTERED SUBCUTANEOUSLY BY AN AUTOINJECTOR OR PREFILLED SYRINGE IN HEALTHY MALE SUBJECTS
    Afonso, M.
    Kollins, D.
    Macke, L.
    Woehling, H.
    Wuerth, G.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 233 - 234
  • [9] Target-Directed Development Of a Proposed Biosimilar Etanercept, GP2015: Comparability Of In Vitro Target Binding and Pre-Clinical Efficacy and Pharmacokinetics
    da Silva, Antonio
    Kronthaler, Ulrich
    Fritsch, Cornelius
    Poetzl, Johann
    Rohde, Adelheid
    Papandrikopoulou, Anastassia
    Hofmann, Hans-Peter
    Visser, Jan Marinus
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S794 - S794
  • [10] GP2015, a proposed etanercept biosimilar: Pharmacokinetic similarity to its reference product and comparison of its autoinjector device with prefilled syringes
    von Richter, Oliver
    Skerjanec, Andrej
    Afonso, Miguel
    Heinrich, Sabine Sanguino
    Poetzl, Johann
    Woehling, Heike
    Velinova, Maria
    Koch, Annelize
    Kollins, Dmitrij
    Macke, Lars
    Wuerth, Guido
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (04) : 732 - 741
12345